These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3363653)

  • 1. Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome.
    Vernillet L; Moulin B; Dadoun C; Le Bigot JF; Fillastre JP
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):529-35. PubMed ID: 3363653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of cyclosporin A in patients with nephrotic syndrome].
    Moulin B; Vernillet L; Dadoun C; Le Bigot JF; Godin M; Fillastre JP
    Nephrologie; 1989; 10(1):17-22. PubMed ID: 2716940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin metabolism in the nephrotic syndrome in adults.
    Jensen H; Rossing N; Andersen SB; Jarnum S
    Clin Sci; 1967 Dec; 33(3):445-57. PubMed ID: 6078513
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacokinetics of cyclosporine A in uremic patients.
    Lindberg A; Odlind B; Tufveson G; Lindström B; Gabrielsson J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):144-52. PubMed ID: 3787709
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine pharmacokinetics in uremic patients: influence of different assay methods.
    Reynolds KL; Grevel J; Gibbons SY; Welsh MS; Rutzky LP; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):462-5. PubMed ID: 3363649
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotransformation of cyclosporin G in comparison to cyclosporine.
    Mangold JB; Schran HF; Yatscoff RW; Weitzel WF; Leichtman AB
    Transplant Proc; 1994 Oct; 26(5):3013-6. PubMed ID: 7940950
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients.
    Tredger JM; Naoumov NV; Steward CM; O'Grady JG; Grevel J; Niven AA; Kelman AW; Whiting B; Williams R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):512-5. PubMed ID: 3284098
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
    Kaysen GA; Jones H; Joles JA; van Tol A
    Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
    El-Melegy NT; Mohamed NA; Sayed MM
    Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solutions of cyclosporine.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):640. PubMed ID: 3363660
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
    Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
    Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of obesity on cyclosporine pharmacokinetics in uremic patients.
    Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464
    [No Abstract]   [Full Text] [Related]  

  • 14. Subcutaneous absorption of cyclosporine in rabbits.
    Shah AK; Sawchuk RJ; Gratwohl A; Baldomero H; Speck B
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):710-4. PubMed ID: 3363667
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular bioavailability of cyclosporine after oral administration.
    Tabbara KF; Gee SS; Alvarez H
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):656-9. PubMed ID: 3363663
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of cyclosporine A and G pharmacokinetics.
    D'Souza MJ; Gourdikian KB; Mujukian AL
    Drug Metab Dispos; 1988; 16(6):895-7. PubMed ID: 2907472
    [No Abstract]   [Full Text] [Related]  

  • 18. [About two cases of massive hypercholesterolemia].
    Perier C; Raby N; Atieh S; Granouillet R; Chamson A
    Ann Biol Clin (Paris); 2005; 63(2):217-9. PubMed ID: 15771981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum apolipoprotein abnormalities in patients with idiopathic nephrotic syndrome].
    Zhang H; Huang WC; Tang SC
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):542-4, 582-3. PubMed ID: 7842352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.